Tradestie Institutional Equity Comparison Engine

MREO vs ATON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MREO Overall Edge

MREO Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mereo BioPharma Group plc American Depositary Shares (MREO) driven by superior Valuation, Momentum & Technical, Options & Structure while ATON counters with relative strength in Growth & Margin. Fundamentally, MREO trades at 113.9x Forward P/E with -3702.5% operating margin (+0.0% YoY revenue) versus ATON at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MREO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against ATON sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MREO
MREO 113.9x vs ATON N/M Fwd P/E
Growth & Margin Winner ATON
Op Margin -3702.5% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner MREO
1Y -83.0% vs -95.9% ยท 52W Pos 5% vs 0%
Options & Structure Winner MREO
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
MREO NASDAQ
Mereo BioPharma Group plc American Depositary Shares
Pharmaceutical Preparations
$0.30
-1.33% 1D
Market Cap $48.7M
1M Return +0.13%
1Y Return -82.96%
Forward P/E 113.9x
Unified AI Score
46.9 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 70.0
ATON NASDAQ
AlphaTON Capital Corp. Common Stock
Finance Services
$0.32
+0.0% 1D
Market Cap $7.5M
1M Return -6.71%
1Y Return -95.94%
Forward P/E N/M
Unified AI Score
45.1 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 35.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MREO -82.96% ATON -95.94% Spread: +9.84 pp (MREO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MREO TTM Op. Margin: -3702.5% ATON TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MREO vs ATON. Trailing 12-month operating profitability (MREO -3702.5% vs ATON 0.0%) and valuation multiples (MREO 113.9x vs ATON N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MREO (6) vs ATON (1)
Institutional Metric MREO ATON Criterion Row Winner
Market Capitalization Scale $48.7M $7.5M Larger Scale MREO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation 113.9x N/M Lower Multiple MREO
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability -3702.5% 0.0% Higher Margin ATON
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -76.6% -311.0% Higher ROE MREO
52-Week Range Position Momentum 5% ($0โ€“$2) 0% ($0โ€“$14) Stronger Trend MREO
Beta / 30D Volatility Risk Regime 1.09ฮฒ ยท 48% Vol 1.90ฮฒ ยท 65% Vol Lower Realized Risk MREO
Unified Institutional Score Composite Signal 46.9 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite MREO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MREO vs ATON Buy Guide
MREO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live MREO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATON UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ATON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MREO nor ATON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.